entitlement not, page-27

IMO, if this company has a future, they will buy post AGM on market. The problem being is in their corp transparency - I believe they have stated, after ASX enquiries previously, that they may have at any time market sensitive info but will not release to protect their IP. Very unusual.

This whole company is very unusual IMO.

They have a current diluted market cap of $41m post AGM but $300K in the bank and even when the current SLACFs are exercised and the first tranche of the 10c one are provided, they are not going to have much either.

I really hope they come good with their projections from Septemeer. In-patient demand in 9 hospitals will happen IMO and has already been factored in.